News

Mark Johnson joins The RSA Group as Partner

Wed, 06/02/2019 - 07:30

£30 Million global cardiovascular disease challenge – now open for applications

Thu, 24/01/2019 - 13:00
PolyCYPs kits

Hypha Discovery launches new PolyCYPs® kits to support drug development and candidate optimisation

Tue, 22/01/2019 - 08:00

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Mon, 14/01/2019 - 07:30

Festival of Genomics returns to London to help shape the future of precision medicine

Mon, 17/12/2018 - 08:30

uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target

Wed, 05/12/2018 - 08:30

Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare

Tue, 27/11/2018 - 08:30
Solentim

Solentim wins place in Deloitte UK Technology Fast 50

Fri, 16/11/2018 - 12:48
Synpromics Fast 50

Synpromics named among the top 50 fastest growing technology companies in the UK

Fri, 16/11/2018 - 12:45
Pharma Integrates 2018

Pharma Integrates brings key opinion leaders together to shape the future of healthcare

Thu, 15/11/2018 - 10:00

Pages